Junshi Biotech announced that the shareholder Shanghai Tanying Investment Partnership reduced its A-share holdings by 12 million shares through bulk transactions between September 5, 2025 and December 4, 2025, accounting for 1.1688% of the company's total share capital. The price range of reduced holdings was 43.13 to 48.46 yuan/share, and the total amount of reduced holdings was 558 million yuan. After the reduction in holdings, Shanghai Tanying held 594.593 million shares of the company, accounting for 5.7914% of the company's total share capital.

Zhitongcaijing · 1d ago
Junshi Biotech announced that the shareholder Shanghai Tanying Investment Partnership reduced its A-share holdings by 12 million shares through bulk transactions between September 5, 2025 and December 4, 2025, accounting for 1.1688% of the company's total share capital. The price range of reduced holdings was 43.13 to 48.46 yuan/share, and the total amount of reduced holdings was 558 million yuan. After the reduction in holdings, Shanghai Tanying held 594.593 million shares of the company, accounting for 5.7914% of the company's total share capital.